Skip to main content
Premium Trial:

Request an Annual Quote

University of Illinois to Use Former NCSA Supercomputer for Genomics, Transcriptomics Research


The National Center for Supercomputing Applications has awarded the Institute of Genomic Biology at the University of Illinois, Urbana-Champaign, with a shared memory supercomputer named Ember, which the university will use for computational genomics and transcriptomics research.

Ember will be managed by the IGB's high-performance biological computing group. The two-year old system was previously part of the NCSA but was decommissioned in October. It has been installed at IGB, adding 1,536 cores and eight terabytes of memory to an existing cluster at the center.

IGB's researchers have used Ember for some genomics projects in the past while it was under NCSA, according to Victor Jongeneel, HPCBio's director.

Now, "having it under our own management will allow us better access and faster results," he said in a statement. "It can perform a lot of tasks that our existing systems just can't."

Ember will be available for on-campus use for an undisclosed service fee that will be placed in a fund that will be used to replace the infrastructure as it ages, U of I said.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.